sumi.news
Search
Following
Sign in
← Back to news
Markets
RSS Feed
sumi.news
Markets
Follow
Latest
Mon Oct 27
TrustLinq Launches Swiss-Regulated Crypto-to-Fiat Payment Platform to boost Cryptocurrency Adoption
2d
Y
Flow Traders Opens New Institutional Gateway to DeFi With Cap and EigenLayer
2d
Y
Nearly 1 in 4 American households living paycheck to paycheck, report reveals
2d
Y
Reitrees: Adams Diversified (ADX) Yields 8.1% And No One Has Heard Of It
2d
Y
Is Wall Street Bullish or Bearish on Mettler-Toledo Stock?
2d
Y
The new battlefield: where capital, regulation and technology collide
2d
Y
The Coming Bitcoin Treasury Bubble
2d
Y
Private equity’s expanding exit playbook: why a slowdown in IPOs shouldn’t worry you
2d
Y
Kraken launches Mastercard for UK, European users as neobank race heats up
2d
Y
BitMine (BMNR) Stock Jumps 15% But Misses Critical Recovery Signal By Inches
2d
Y
Billions of dollars in credit card rewards are going unused. Here’s how to get the most from your cards
2d
Y
NIO (NIO) Q3 2025 Earnings Call Transcript
2d
Y
Is Freeport-McMoRan Stock Underperforming the Nasdaq?
2d
Y
Nvidia: The Next Growth Frontier Is Sovereign AI
2d
S
Michael Burry's next 'Big Short': An inside look at his analysis showing AI is a bubble
2d
F
More Than 1 in 3 Americans Will Delay Retirement Due to Financial Challenges — Here’s Why
2d
Y
Strategy, Robinhood, and Coinbase Stocks Slide. One Reason Not to Worry.
2d
Y
Is Zoetis Stock Underperforming the Dow?
2d
Y
Exodus’ W3C Deal Adds Stability as Firm Builds Full Payments Stack: Benchmark
2d
Y
Kohl’s Stock Soars 26% After Earnings. Yes, Kohl’s.
2d
Y
How Is ICE’s Stock Performance Compared to Other Broker-Dealer & Securities Exchange Stocks?
2d
Y
Bitcoin Miners Face Worst Profit Crisis Ever — Giants are Turning Off Rigs and Chasing Bigger Money in AI
2d
Y
Is Cal-Maine Foods (CALM) The Top Long-Term Stock to Buy?
2d
Y
What Are Wall Street Analysts' Target Price for W.W. Grainger Stock?
2d
Y
Taurus Expands Institutional Footprint With Super Validator Role on Canton Network
2d
Y
Novo Nordisk (NVO) is Trending On Reddit – Here’s Why
2d
Y
Is QXO (QXO) The Best Stock to Benefit from Fed’s Interest Rate Cuts?
2d
Y
Retail Investors on Reddit Like Costco Wholesale (COST), Here’s Why
2d
Y
Is Coca-Cola (KO) The Best Dividend Stock to Buy Amid AI Valuation Concerns?
2d
Y
Stocks Waver as Wall Street Finally Gets Retail Sales, Producer Price Inflation Data
2d
Y
NIO Net Loss Narrows on Strong Sales, Margin
2d
Y
What Are Wall Street Analysts' Target Price for Deckers Outdoor Stock?
2d
Y
Is Exxon Mobil Stock Underperforming the S&P 500?
2d
Y
Reddit Loves Waste Management (WM) as a Top Non-AI Stock, Here’s Why
2d
Y
Redditors Are Buying Eli Lilly And Co (LLY) Ahead of Potential End of AI Trade. Here’s Why
2d
Y
Do You Believe in the Upside Potential of Quaker Houghton (KWR)?
2d
Y
FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation
2d
Y
Is Berkshire Hathaway (BRK.B) The Top Stock to Save Your Portfolio Ahead of Potential AI Bubble Pop?
2d
Y
TransDigm Group Stock: Is Wall Street Bullish or Bearish?
2d
Y
H.C. Wainwright Maintains Buy on Atai Beckley (ATAI) Following Breakthrough Therapy and Merger Completion
2d
Y
Agios Pharmaceuticals (AGIO) Upgraded After Mixed Sickle Cell Data and Pending Thalassemia Catalyst
2d
Y
Bitcoin Gets Kicked Out of the $2 Trillion Club. Here's Why This Top Bitcoin ETF Is a Buy Anyway.
2d
Y
Intellia Therapeutics (NTLA) Downgraded After Safety Concerns and Regulatory Delays Slow Gene-Editing Progress
2d
Y
William Blair Maintains Market Perform Rating on uniQure (QURE) Despite AMT-130 Approval Uncertainty
2d
Y
William Blair Maintains Hold Rating on Legend Biotech (LEGN) Despite Carvykti Label Safety Concerns
2d
Y
Mizuho Lowers Price Target on Apellis Pharmaceuticals (APLS) Amid Ongoing Eye Disease Therapy Challenges
2d
Y
Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns
2d
Y
Novavax Shifts From COVID Sales to R&D Focus While Updating 2025 Forecast
2d
Y
Oppenheimer Reaffirms Outlook on CRISPR Therapeutics (CRSP) After Encouraging Q3 Earnings Performance
2d
Y
A Trillion-Dollar Pill: Eli Lilly Broke the Healthcare Ceiling
2d
Y
More →